IPO profile
Sahajanand Medical Technologies Limited
SMT · NSE
- Price band
- ₹327 - ₹344
- Subscription
- 4.29x
Application & Issue Details
- Minimum Quantity
- 43 shares
- Minimum Application
- ₹14,792
- Issue Size
- Rs. 475 Cr
- Face Value
- Not available
- Issue Price
- ₹344
Company Overview
Sahajanand Medical Technologies develops, manufactures, and markets cardiovascular devices globally. The core business is divided into two primary segments: vascular intervention products, such as coronary stents and balloon catheters, and structural heart devices, including transcatheter aortic valves and occluders. The company generates the majority of its revenue from the sale of vascular intervention devices, with the Supraflex Cruz, a biodegradable polymer-based drug-eluting stent, acting as a major contributor to its sales. Products are distributed across India, Europe, and the rest of the world through a combination of direct, hybrid, and distributor-led models, supported by an extensive network of domestic and international distributors. Operations are backed by manufacturing facilities located in Surat, Hyderabad, and Thailand. Additionally, the business relies heavily on dedicated research and development capabilities to continually enhance existing products and introduce new cardiovascular treatments.
Important Dates
- Open Date
- 15 Oct 2026
- Close Date
- 19 Oct 2026
- Allotment Date
- Not available
- Listing Date
- 23 Oct 2026
Issue Timeline
- Issue open date
- Issue close date
- UPI mandate deadline
- Allotment finalization
- Refund initiation
- Share credit
- Listing date
- Mandate end date
- Lock-in end date for anchor investors (50%)
- Lock-in end date for anchor investors (remaining)
Subscription
- QIB
- 6.09x
- NII
- 8.56x
- Retail
- 1.64x
- Total subscribed
- 4.29x
- Shares offered
- 97,50,482
- Shares bid
- 4,18,10,620
Updated 25 Oct 2026, 8:02 pm · source: nse
IPOAlerts subscription snapshot updated 20 Oct 2026, 11:00 pm.
Actual Listing Performance
- Listing Date
- 23 Oct 2026
- Actual Listing Price
- ₹371.15
- Gain/Loss Per Share
- +₹27.15
- Gain/Loss Per Lot
- +₹1,167.45
- Listing Gain/Loss %
- +7.89%
- Measured Against
- ₹344
- Lot Size
- 43 shares
Historical result from the reported listing price, compared with the issue price. Excludes brokerage, taxes and charges.
Company Strengths & Risks
Reported strengths
- Strong portfolio of vascular and structural heart medical devices
- Extensive domestic and international distribution network
- Dedicated in-house research and development capabilities
- Multiple manufacturing facilities across India and Thailand
- Diversified revenue streams from sales in over 65 countries
Key risks
- High dependency on revenues from the Supraflex Cruz stent
- Stringent domestic and global regulatory compliance requirements
- Vulnerability to foreign currency exchange rate fluctuations
- Reliance on limited third-party suppliers for key raw materials
- Exposure to pricing controls and healthcare reimbursement caps
Company strengths and risks are informational summaries. Review the offer document for complete disclosures.
Documents & Coverage
IPO data last updated 25 Oct 2026, 8:02 pm IST · GMP: ipoalerts · subscription: nse · listing price: NSE/BSE
This page is for informational and educational purposes only. It is not investment advice and not a recommendation to buy, sell, or apply for this IPO. GMP and subscription figures are unofficial/may change. Please make your own independent decision.